144 related articles for article (PubMed ID: 11079284)
1. Cost-benefit analysis of sumatriptan tablets versus usual therapy for treatment of migraine.
Biddle AK; Shih YC; Kwong WJ
Pharmacotherapy; 2000 Nov; 20(11):1356-64. PubMed ID: 11079284
[TBL] [Abstract][Full Text] [Related]
2. Cost benefit of sumatriptan to an employer.
Legg RF; Sclar DA; Nemec NL; Tarnai J; Mackowiak JI
J Occup Environ Med; 1997 Jul; 39(7):652-7. PubMed ID: 9253726
[TBL] [Abstract][Full Text] [Related]
3. Costs and outcomes of early versus delayed migraine treatment with sumatriptan.
Halpern MT; Lipton RB; Cady RK; Kwong WJ; Marlo KO; Batenhorst AS
Headache; 2002; 42(10):984-99. PubMed ID: 12453030
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness analysis of rizatriptan and sumatriptan versus Cafergot in the acute treatment of migraine.
Zhang L; Hay JW
CNS Drugs; 2005; 19(7):635-42. PubMed ID: 15984898
[TBL] [Abstract][Full Text] [Related]
5. Sumatriptan: economic evidence for its use in the treatment of migraine, the Canadian comparative economic analysis.
Caro G; Getsios D; Caro JJ; Raggio G; Burrows M; Black L
Cephalalgia; 2001 Feb; 21(1):12-9. PubMed ID: 11298658
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of sumatriptan in reducing productivity loss due to migraine: results of a randomized, double-blind, placebo-controlled clinical trial.
Schulman EA; Cady RK; Henry D; Batenhorst AS; Putnam DG; Watson CB; O'Quinn SO
Mayo Clin Proc; 2000 Aug; 75(8):782-9. PubMed ID: 10943230
[TBL] [Abstract][Full Text] [Related]
7. Triptans to the rescue: effective therapy for migraine headaches in the workplace.
Bartleson JD
Mayo Clin Proc; 2000 Aug; 75(8):780-1. PubMed ID: 10943229
[No Abstract] [Full Text] [Related]
8. Pharmacoeconomic evidence and considerations for triptan treatment of migraine.
Caro JJ; Getsios D
Expert Opin Pharmacother; 2002 Mar; 3(3):237-48. PubMed ID: 11866674
[TBL] [Abstract][Full Text] [Related]
9. Impact of chest pain on cost of migraine treatment with almotriptan and sumatriptan.
Wang JT; Barr CE; Goldfarb SD
Headache; 2002 Jan; 42 Suppl 1():38-43. PubMed ID: 11966863
[TBL] [Abstract][Full Text] [Related]
10. Oral serotonin receptor agonists: a review of their cost effectiveness in migraine.
Lofland JH; Nash DB
Pharmacoeconomics; 2005; 23(3):259-74. PubMed ID: 15836007
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of migraine treatment: a commentary.
Smith DG
Value Health; 2003; 6(4):436-7. PubMed ID: 12859584
[No Abstract] [Full Text] [Related]
12. Sumatriptan. A pharmacoeconomic review of its use in migraine.
Coukell AJ; Lamb HM
Pharmacoeconomics; 1997 May; 11(5):473-90. PubMed ID: 10168035
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness and cost-benefit of sumatriptan in patients with migraine.
Lofland JH; Kim SS; Batenhorst AS; Johnson NE; Chatterton ML; Cady RK; Kaniecki R; Nash DB
Mayo Clin Proc; 2001 Nov; 76(11):1093-101. PubMed ID: 11702897
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the cost-effectiveness of almotriptan and sumatriptan in the treatment of acute migraine using a composite efficacy/tolerability end point.
Williams P; Reeder CE
J Manag Care Pharm; 2004; 10(3):259-65. PubMed ID: 15228377
[TBL] [Abstract][Full Text] [Related]
15. Rizatriptan: a pharmacoeconomic review of its use in the acute treatment of migraine.
McCormack PL; Foster RH
Pharmacoeconomics; 2005; 23(12):1283-98. PubMed ID: 16336021
[TBL] [Abstract][Full Text] [Related]
16. Assessment of clinical, service, and cost outcomes of a conversion program of sumatriptan to rizatriptan ODT in primary care patients with migraine headaches.
Gershovich OE; Billups SJ; Delate T; Hoffman CK; Carroll N
J Manag Care Pharm; 2006 Apr; 12(3):246-53. PubMed ID: 16623609
[TBL] [Abstract][Full Text] [Related]
17. Subcutaneous sumatriptan compared with usual acute treatments for migraine: clinical and pharmacoeconomic evaluation.
Laloux P; Vakaet A; Monseu G; Jacquy J; Bourgeois P; van der Linden C
Acta Neurol Belg; 1998 Dec; 98(4):332-41. PubMed ID: 9922821
[TBL] [Abstract][Full Text] [Related]
18. The effect of early intervention with sumatriptan tablets on migraine-associated productivity loss.
Kwong WJ; Taylor FR; Adelman JU
J Occup Environ Med; 2005 Nov; 47(11):1167-73. PubMed ID: 16282878
[TBL] [Abstract][Full Text] [Related]
19. An economic evaluation of rizatriptan in the treatment of migraine.
Thompson M; Gawel M; Desjardins B; Ferko N; Grima D
Pharmacoeconomics; 2005; 23(8):837-50. PubMed ID: 16097844
[TBL] [Abstract][Full Text] [Related]
20. Impact of sumatriptan on clinic utilization and costs of care in migraineurs.
Litaker DG; Solomon GD; Genzen JR
Headache; 1996 Oct; 36(9):538-41. PubMed ID: 8916561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
